In Parkinson's disease patients, Humanin mRNA levels in peripheral blood mononuclear cells were higher than in controls.
In plain wordsIn people with Parkinson's disease, the body's own humanin gene activity in blood cells was higher than in healthy controls.
- Peptide
- Humanin
- Outcome
- IncreaseHumanin mRNA in PBMCs
- Study
n = 220
- Comparator
- Normal control subjects
- Outcome group
- Neuroprotection · Nervous system and cognition
Source sentences
Increased Humanin mRNA levels were found in PD samples, compared to controls.
2 context sentences(design, population, supporting numbers)
A total of 220 participants, including 154 PD patients (57 females and 97 males; mean age 71.54 years, SD 7.8) and 66 CN (28 females and 38 males; mean age 70.54 years, SD 9.45) were enrolled for the qRT-PCR analysis.
The purpose of the present study was to evaluate Humanin mRNA levels in peripheral blood mononuclear cells (PBMCs) of PD subjects, compared with those in PBMCs of normal control (NC) subjects.
This result measures the body's own Humanin. Nobody was given the peptide. It is not evidence about taking it.